International Biotechnology Trust (IBT) has delivered strong returns over the past year, the NAV is up 30% over the year to date, well ahead of its benchmark, and wider national and global indices. The pandemic has focused attention on the sector as a number of companies search for effective treatments and vaccines. The sector has recovered some ground relative to wider indices but – as is typical – the US election has been weighing on valuations. IBT’s managers highlight that the real drivers o ....
11 Nov 2020
Healthy returns
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Healthy returns
International Biotechnology Trust PLC (IBT:LON) | 626 62.6 1.6% | Mkt Cap: 236.7m
- Published:
11 Nov 2020 -
Author:
Ed Marten -
Pages:
20
International Biotechnology Trust (IBT) has delivered strong returns over the past year, the NAV is up 30% over the year to date, well ahead of its benchmark, and wider national and global indices. The pandemic has focused attention on the sector as a number of companies search for effective treatments and vaccines. The sector has recovered some ground relative to wider indices but – as is typical – the US election has been weighing on valuations. IBT’s managers highlight that the real drivers o ....